
Opinion|Videos|May 15, 2024
FDA-approved Therapies for Geographic Atrophy
An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: BRUNELLO 1-year results for remigromig in DME
2
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
3
AAO 2026: MCO-010 sustains vision gains in RP through 4 years
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5



















